Plasma Metabolites Forecast Occurrence and Prognosis for Patients With Diffuse Large B-Cell Lymphoma

Plasma Metabolites Forecast Occurrence and Prognosis for Patients With Diffuse Large B-Cell Lymphoma

BackgroundDiffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin’s lymphoma with considerable heterogeneity and different clinical prognosis. However, plasma metabomics used to forecast occurrence and prognosis of DLBCL are rarely addressed.MethodA total of 65 volunteers including 22 h...

Full description

Bibliographic Details
Main Authors: Fei Fei, Meihong Zheng, Zhenzhen Xu, Runbin Sun, Xin Chen, Bei Cao, Juan Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
diffuse large B-cell lymphoma
metabolomics
metabolic heterogeneity
biomarker discovery
malate
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.894891/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.894891/full

Similar Items